Finally, a recent study by Rahal and collegues [87] identified a subset of MCL lines with chronic activation of the BCR mediated CBM–NF-κB signaling pathway and constitutive RelB cleavage, suggesting that a subset of MCL may also be responsive to MALT1 inhibition. The gene discussed is BCR; the disease is mantle cell lymphoma.